Nuvation Bio Inc. — Director's Dealing 2022

May 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2022-05-23

Reporting Person: Wentworth Kerry (Chief Regulatory Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-23	Stock Option (Right to Buy)	$3.78	A	330000	Acquired	2032-05-22	Common Stock (330000)	Direct
2022-05-23	Stock Option (Right to Buy)	$3.78	A	247500	Acquired	2032-05-22	Common Stock (247500)	Direct

Footnotes

F1: Option vests as to 25% on the one year anniversary of 5/23/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.

F2: The shares subject to the Options will vest based on the satisfaction of both time-based and performance-based vesting criteria.